Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.660
-0.060 (-3.49%)
At close: Nov 20, 2024, 4:00 PM
1.700
+0.040 (2.41%)
After-hours: Nov 20, 2024, 6:33 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $42.39 million as of November 21, 2024. Its market cap has increased by 21.82% in one year.
Market Cap
42.39M
Enterprise Value
31.11M
1-Year Change
21.82%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $42.39M, a decrease of -65.99%. That is a compound annual growth rate of -25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 42.39M | -14.15% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 44.46M |
| SCYNEXIS | 44.39M |
| Actinium Pharmaceuticals | 44.30M |
| OncoCyte | 44.28M |
| Intensity Therapeutics | 43.24M |
| Achilles Therapeutics | 43.14M |
| Daxor | 43.11M |
| OS Therapies | 43.02M |